Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX Multi-Cord Study
Safety Profile Consistent with Clinical Trials MALVERN, Pa., Sept. 7, 2011 /PRNewswire/ — AuxiliumPharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceuticalcompany, today announced positive top-line results from a pilotclinical…
September 7th, 2011
Posted in
Drug

